📗 Cite This Artifact
CAV1 Protein
Caveolin-1 (CAV1) — Structure, Function, and Role in Neurodegeneration
<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Caveolin-1 Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Caveolin-1</td></tr>
<tr><td><strong>Gene Symbol</strong></td><td>[CAV1](/genes/cav1)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q03135](https://www.uniprot.org/uniprot/Q03135)</td></tr>
<tr><td><strong>PDB Structure</strong></td><td>1DG6, 4HID</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>22 kDa (178 aa)</td></tr>
<tr><td><strong>Subcellular Location</strong></td><td>Plasma membrane, caveolae, endosomes, Golgi</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Caveolin family</td></tr>
<tr><td><strong>Expression</strong></td><td>Neurons, astrocytes, endothelial cells</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/anxiety" style="color:#ef9a9a">Anxiety</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">171 edges</a></td>
</tr>
</table>
</div>
Overview
...
Caveolin-1 (CAV1) — Structure, Function, and Role in Neurodegeneration
<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Caveolin-1 Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Caveolin-1</td></tr>
<tr><td><strong>Gene Symbol</strong></td><td>[CAV1](/genes/cav1)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q03135](https://www.uniprot.org/uniprot/Q03135)</td></tr>
<tr><td><strong>PDB Structure</strong></td><td>1DG6, 4HID</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>22 kDa (178 aa)</td></tr>
<tr><td><strong>Subcellular Location</strong></td><td>Plasma membrane, caveolae, endosomes, Golgi</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Caveolin family</td></tr>
<tr><td><strong>Expression</strong></td><td>Neurons, astrocytes, endothelial cells</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/anxiety" style="color:#ef9a9a">Anxiety</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">171 edges</a></td>
</tr>
</table>
</div>
Overview
Caveolin-1 (CAV1) is a 22 kDa scaffolding protein that serves as the primary structural component of caveolae— flask-shaped invaginations of the plasma membrane. Beyond its well-characterized role in membrane organization, CAV1 plays critical roles in neuronal function, synaptic plasticity, and has emerged as a significant player in neurodegenerative disease pathogenesis [1].
Caveolae constitute approximately 15-20% of the neuronal plasma membrane surface and serve as critical signaling platforms that concentrate receptors, second messengers, and downstream effectors [6]. The caveolin protein family includes CAV1, CAV2, and CAV3, with CAV1 being the most widely expressed in the central nervous system.
Structure and Biochemistry
Domain Architecture
Caveolin-1 contains several distinct structural domains:
- Scaffolding domain ( residues 82-101): Critical for protein-protein interactions and signaling regulation
- Oligomerization domain (residues 1-97): Mediates formation of high-molecular-weight complexes
- C-terminal domain: Involved in membrane association and protein interactions
The protein forms homooligomers of approximately 16-24 monomers that assemble into the characteristic caveolae structure [6]. Each CAV1 monomer has a hydrophobic hairpin that inserts into the inner leaflet of the plasma membrane, creating the characteristic flask-shaped invagination.
Post-Translational Modifications
CAV1 undergoes several important post-translational modifications:
- Phosphorylation: Tyr-14 phosphorylation regulates interactions with downstream signaling molecules
- Palmitoylation: Cys-133 palmitoylation stabilizes membrane association
- Ubiquitination: Regulates protein turnover and degradation
Normal Neuronal Function
Synaptic Signaling Platforms
In neurons, CAV1 is enriched at synaptic membranes where it serves several essential functions:
Membrane Trafficking
CAV1 regulates endocytic and exocytic trafficking pathways critical for synaptic vesicle recycling and neurotransmitter release. The protein interacts with components of the endocytic machinery including dynamin and clathrin adaptor proteins.
Neuronal Survival
CAV1 provides neuroprotective effects through multiple mechanisms [4]:
- Regulation of neurotrophic factor signaling
- Modulation of calcium homeostasis
- Protection against oxidative stress
- Maintenance of mitochondrial function
Role in Alzheimer's Disease
Amyloid-β Interaction
Recent research has revealed a critical role for CAV1 in amyloid-β (Aβ) uptake and toxicity [2]. The cellular prion protein (PrP^C) acts as a mediator of Aβ uptake by CAV1, leading to:
- Enhanced Aβ internalization through caveolae-dependent endocytosis
- Disruption of caveolae-mediated signaling
- Acceleration of synaptic dysfunction
Synaptic Dysfunction
CAV1 expression is altered in Alzheimer's disease brains, contributing to synaptic loss:
- Reduced CAV1 levels correlate with cognitive decline in AD patients
- CAV1 deficiency leads to accelerated neurodegeneration in mouse models
- Loss of caveolae integrity compromises synaptic receptor organization
Therapeutic Potential
Gene therapy approaches using neuron-targeted CAV1 overexpression have shown promise [5]:
- Preserves synaptic morphology in AD mouse models
- Prevents neuronal loss
- Attenuates cognitive deficits
- Normalizes pathological gene expression changes
The Synapsin-CAV1 fusion construct enables neuron-specific expression and represents a promising therapeutic strategy for AD.
Role in Parkinson's Disease
In Parkinson's disease, CAV1 is implicated in:
- Dopaminergic neuron survival: CAV1 protects against toxin-induced cell death
- α-Synuclein aggregation: Caveolae may serve as entry points for extracellular α-synuclein
- Mitochondrial function: CAV1 regulates mitochondrial dynamics and quality control
- Neuroinflammation: Modulates glial activation and inflammatory responses
Interaction Network
Therapeutic Targeting
Several strategies are being explored to target CAV1 in neurodegeneration:
Cross-Links
- [CAV1 Gene](/genes/cav1) — Gene page for CAV1
- [Alzheimer's Disease](/diseases/alzheimers-disease) — Primary disease association
- [Parkinson's Disease](/diseases/parkinsons-disease) — Related neurodegenerative disease
- [Synaptic Dysfunction](/mechanisms/synaptic-dysfunction) — Related mechanism
- [Amyloid Cascade](/mechanisms/amyloid-cascade) — Related pathway
- [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction) — Related mechanism
Summary
Caveolin-1 is a multifunctional scaffolding protein essential for neuronal health. Through its role in organizing caveolae, regulating synaptic signaling, and maintaining cellular homeostasis, CAV1 provides critical neuroprotective functions. In Alzheimer's disease, loss of CAV1 function contributes to synaptic dysfunction and cognitive decline, while its interaction with amyloid-β and the cellular prion protein reveals new pathological mechanisms. Therapeutic approaches targeting CAV1, particularly through gene therapy, represent a promising avenue for disease-modifying treatment in neurodegeneration.
See Also
- [CAV1 Gene](/genes/cav1)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Synaptic Dysfunction](/mechanisms/synaptic-dysfunction)
- [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction)
- [Neuroprotection](/therapeutics/neuroprotection)
References
Related Hypotheses
From the [SciDEX Exchange](/exchange) — scored by multi-agent debate
- [Synthetic Biology BBB Endothelial Cell Reprogramming](/hypothesis/h-84808267) — <span style="color:#ffd54f;font-weight:600">0.56</span> · Target: TFR1, LRP1, CAV1, ABCB1
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | proteins-cav1-protein |
| kg_node_id | CAV1PROTEIN |
| entity_type | protein |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-893c65c4830e |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-cav1-protein'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-proteins-cav1-protein?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[CAV1 Protein](http://scidex.ai/artifact/wiki-proteins-cav1-protein)
http://scidex.ai/artifact/wiki-proteins-cav1-protein